z-logo
open-access-imgOpen Access
Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome
Author(s) -
Morad Kamand,
Mirolyuba Ilieva,
Sheena Louise Forsberg,
Mads Thomassen,
Morten Meyer,
Åsa Fex Svenningsen,
Tanja Maria Michel
Publication year - 2020
Publication title -
stem cell research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.654
H-Index - 65
eISSN - 1876-7753
pISSN - 1873-5061
DOI - 10.1016/j.scr.2020.101974
Subject(s) - biology , induced pluripotent stem cell , stem cell , asperger syndrome , genetics , embryonic stem cell , medicine , bioinformatics , autism , psychiatry , gene , psychology
Autism spectrum disorder is a heterogenous neurodevelopmental disorder. The patients experience challenges in social interaction and communication skills as well as restricted and/or repetitive behaviors. To understand the molecular mechanisms underlying developmental brain disorders, patient-derived cellular models represent a useful tool. We have generated a human induced pluripotent stem cell line (SDUKIi003-A) from skin fibroblasts derived from a 20-year old male patient diagnosed with Asperger syndrome ("FYNEN-cohort" of Southern Denmark). The reprogramming of the fibroblasts was accomplished using integration-free episomal plasmids. Characterization validated the expression of pluripotency markers, differentiation into the three germ layers, and absence of chromosomal abnormalities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom